| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |